Lucid Diagnostics Inc. Increase (Decrease) in Interest Payable, Net
Lucid Diagnostics Inc. (LUCD) reported Increase (Decrease) in Interest Payable, Net of $12.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2025-11-12
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for the quarter ending 2025-09-30 was -$4.00K.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for the quarter ending 2025-06-30 was $7.00K.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for the quarter ending 2025-03-31 was $9.00K.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for the quarter ending 2024-12-31 was -$63.00K.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for fiscal 2024 was -$4.67M, a 206.71% decline from fiscal 2023.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for fiscal 2023 was $4.38M, a 42.91% decline from fiscal 2022.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for fiscal 2022 was $7.67M, a 150.96% increase from fiscal 2021.
- Lucid Diagnostics Inc. increase (decrease) in interest payable, net for fiscal 2021 was $3.06M.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.00K derived: sum of 2 quarters · filed 2025-11-12 | $12.00K 10-Q · filed 2025-11-12 | -$51.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $16.00K 10-Q · filed 2025-08-12 | -$47.00K derived: sum of 3 quarters · filed 2025-08-12 | -$259.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $9.00K 10-Q · filed 2025-05-13 | -$54.00K derived: sum of 2 quarters · filed 2025-05-13 | -$266.00K derived: sum of 3 quarters · filed 2025-11-12 | -$1.87M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$275.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.88M derived: sum of 3 quarters · filed 2025-11-12 | -$4.67M 10-K · filed 2025-03-24 |
| 2024-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.82M derived: sum of 2 quarters · filed 2025-11-12 | -$4.61M 10-Q · filed 2025-11-12 | -$5.56M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$4.40M 10-Q · filed 2025-08-12 | -$5.34M derived: sum of 3 quarters · filed 2025-08-12 | -$5.76M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$2.79M 10-Q · filed 2025-05-13 | -$3.74M derived: sum of 2 quarters · filed 2025-05-13 | -$4.15M derived: sum of 3 quarters · filed 2025-05-13 | -$1.08M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$1.36M derived: sum of 2 quarters · filed 2025-03-24 | $1.71M derived: sum of 3 quarters · filed 2025-03-24 | $4.38M 10-K · filed 2025-03-24 |
| 2023-09-30 | -$411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.66M derived: sum of 2 quarters · filed 2024-11-12 | $5.33M 10-Q · filed 2024-11-12 | $10.15M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $5.74M 10-Q · filed 2024-08-12 | $10.56M derived: sum of 3 quarters · filed 2024-08-12 | $14.74M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $2.67M 10-Q · filed 2024-05-13 | $7.49M derived: sum of 2 quarters · filed 2024-05-13 | $11.67M derived: sum of 3 quarters · filed 2024-05-13 | $10.23M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $9.01M derived: sum of 2 quarters · filed 2024-03-25 | $7.56M derived: sum of 3 quarters · filed 2024-03-25 | $7.67M 10-K · filed 2024-03-25 |
| 2022-09-30 | $4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.74M derived: sum of 2 quarters · filed 2023-11-13 | $2.85M 10-Q · filed 2023-11-13 | $5.31M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.33M 10-Q · filed 2023-08-14 | $1.13M derived: sum of 3 quarters · filed 2023-08-14 | $1.58M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $113.00K 10-Q · filed 2023-05-15 | $2.58M derived: sum of 2 quarters · filed 2023-05-15 | $3.02M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $2.91M derived: sum of 2 quarters · filed 2023-03-14 | $3.06M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $447.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $594.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $147.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |